New fund provides £2.95m boost to Scottish universities to commercialise research

Deputy First Minister Kate Forbes saw demonstrations from three of the successful projects receiving funding during a visit to the University of Edinburgh Institute for Genetics and Cancer
A pioneering anti-cancer drug, potentially 500 times more potent than current treatments, is one of 18 projects to receive a share of a new £2.95 million fund designed to commercialise ground-breaking academic research.
The £2.95m Proof of Concept Fund will support the commercialisation of ground-breaking research across ten Scottish universities including the project targeting blood and solid cancers at the University of Edinburgh. The £125,000 awarded to the project will fund further studies, ensuring it meets industry standards.
The pilot Proof of Concept Fund is awarded to projects that address significant global challenges across a range of sectors including Life Sciences, Quantum, Photonics, Aerospace, AI and Fintech. Projects include:
- A laser system which quickly detects aircraft engine faults
- A non-invasive, radiation-free ultrasound to detect breast cancer
- A more sustainable and healthier alternative to palm oil
Funding will enable researchers to demonstrate the feasibility of projects through developing prototypes, market exploration and achieving regulatory approvals to derisk new technologies and attract investment. The projects have significant and largely untapped economic opportunities, with potential wide-ranging societal benefits.
Deputy First Minister Kate Forbes saw demonstrations from three of the successful projects receiving funding during a visit to the University of Edinburgh Institute for Genetics and Cancer.
Ms Forbes said: “Our first National Innovation Week was a declaration of intent by the Scottish Government. Innovation must be our national endeavour and we are supporting it across all areas of society.
“Scotland’s world-class universities have the ideas and inventions to help tackle global problems and improve lives. This new Proof of Concept Fund and will help bridge the gap between theory and practice, translating research into real-world impact which in turn drives Scotland’s economic transformation.
“The successful projects that we are supporting are quite simply inspiring. They have the potential to be lifesaving and life changing.”
Professor David Argyle, Vice-Principal and Head of College of Medicine and Veterinary Medicine at the University of Edinburgh, said: “The transition from ground-breaking discovery to real-world application is one of the most critical stages in research.
“This funding is a welcome endorsement of the exceptional innovation underway across Scotland, supporting academics to achieve commercial success. At Edinburgh, the investment in pioneering cancer treatments, lab-grown tissue models and improved detection of aircraft faults shows how this work can hugely benefit people’s lives while also strengthening the economy.”